Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern are ...

The coronavirus disease 2019 (COVID-19) pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely impacted public health worldwide, leading to millions of ...

More than 80% of patients have ear, nose, and throat involvement. Patients with ANCA-associated vasculitis (AAV) and central diabetes insipidus (CDI) have a higher burden of ear, nose, and throat (ENT ...

Please provide your email address to receive an email when new articles are posted on . A group of representatives from national and international endocrine, nephrology and pediatric societies has ...

Eton Pharmaceuticals submitted an NDA for ET-600, an oral solution for central diabetes insipidus, targeting a Q1 2026 launch. Eton Pharmaceuticals announced the submission of a New Drug Application ...

Please provide your email address to receive an email when new articles are posted on . National and international endocrine, nephrology and pediatric societies are proposing a name change for ...

Diabetes mellitus – known to many as type 1 and type 2 diabetes – gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known ...

Diabetes insipidus occurs when problems with antidiuretic hormone (ADH) cause the body to remove too much water. A synthetic version of ADH can help restore a person’s levels and treat some types of ...

Eton Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ET-600, a proprietary oral solution of desmopressin aimed at ...